IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

LUBRANO DI SCORPANIELLO, Ennio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.774
EU - Europa 4.978
AS - Asia 553
AF - Africa 359
SA - Sud America 30
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 14
Totale 11.727
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.753
IE - Irlanda 1.954
UA - Ucraina 532
IT - Italia 471
FI - Finlandia 443
AT - Austria 363
CI - Costa d'Avorio 349
DE - Germania 335
SE - Svezia 319
CN - Cina 264
FR - Francia 253
GB - Regno Unito 199
SG - Singapore 141
IN - India 51
RU - Federazione Russa 26
BE - Belgio 22
TR - Turchia 19
CA - Canada 18
AU - Australia 17
BR - Brasile 16
IR - Iran 15
EU - Europa 14
VN - Vietnam 14
NL - Olanda 13
IL - Israele 9
KZ - Kazakistan 9
CZ - Repubblica Ceca 8
ES - Italia 8
CH - Svizzera 6
CL - Cile 6
HR - Croazia 6
JP - Giappone 6
RO - Romania 6
CO - Colombia 4
EG - Egitto 4
GR - Grecia 4
IQ - Iraq 4
MY - Malesia 4
PL - Polonia 4
TH - Thailandia 3
BD - Bangladesh 2
DK - Danimarca 2
ID - Indonesia 2
KR - Corea 2
LK - Sri Lanka 2
MA - Marocco 2
MX - Messico 2
NZ - Nuova Zelanda 2
PE - Perù 2
TW - Taiwan 2
ZA - Sudafrica 2
AR - Argentina 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
HK - Hong Kong 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 11.727
Salva come PNG Salva come JPEG
Città #
Dublin 1.954
Jacksonville 1.319
Chandler 1.133
Wilmington 409
Vienna 361
Abidjan 349
Helsinki 303
Rome 266
Houston 248
San Mateo 247
Ann Arbor 185
Princeton 179
Woodbridge 146
Boardman 143
Dearborn 94
Singapore 83
Beijing 62
Ashburn 57
Los Angeles 44
New York 43
Redwood City 41
Mountain View 36
Molise 34
Jinan 26
Brussels 19
Nanjing 18
Falls Church 17
Shenyang 16
Milan 15
Ningbo 14
Auburn Hills 13
Leawood 13
Augusta 12
Frankfurt am Main 12
Haikou 12
Ardabil 10
Dong Ket 10
Nuremberg 10
Seattle 10
Borås 9
Chicago 9
Guangzhou 9
Norwalk 9
Rockville 9
Esslingen am Neckar 8
London 8
Manchester 8
Taizhou 8
Zhengzhou 8
Changsha 7
Hefei 7
Monmouth Junction 7
Olomouc 7
Shanghai 7
Tianjin 7
Detroit 6
Fairfield 6
Nanchang 6
Simi Valley 6
São Paulo 6
Taiyuan 6
Astana 5
Chennai 5
Falkenstein 5
Kunming 5
San Francisco 5
St Louis 5
Tappahannock 5
Almaty 4
Fleet 4
Fuzhou 4
Greenford 4
Hebei 4
Istanbul 4
Jiaxing 4
Lappeenranta 4
Quzhou 4
Renton 4
Amsterdam 3
Ariccia 3
Bangkok 3
Berlin 3
Cagliari 3
Castelfidardo 3
Costa 3
Fermignano 3
Florence 3
Hangzhou 3
Hanoi 3
Lanzhou 3
Mumbai 3
Novokuznetsk 3
Ottawa 3
Oxford 3
Padova 3
Phoenix 3
Rochester 3
San Genesio Ed Uniti 3
Sommatino 3
Sydney 3
Totale 8.267
Salva come PNG Salva come JPEG
Nome #
An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment 120
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting 103
Venous thrombophilia in a patient with protein S deficiency, factor V Leiden and homozygous MTHFR C -> T677 mutation 101
Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study 99
Iperuricemia e rischio cardio-renale 97
Validity, responsiveness and feasibility of an Italian version of the Canadian Occupational Performance Measure for patients with ankylosing spondylitis 95
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. 93
La spondilodiscite delle spondiloartriti sieronegative 92
Validity and reliability of an Italian version of the revised Leeds disability questionnaire for patients with ankylosing spondylitis 91
Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors 91
Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study 91
Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions 89
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients 89
The arthritis of coeliac disease: prevalence and pattern in 200 adult patients 88
Simple clinical indicators for early psoriatic arthritis detection. 87
Trauma and seronegative spondylarthropathy 84
Venous thrombophilia with severe mesenteric involvement associated to homozygosity for factor V Leiden and heterozygosity for G20210A mutation of prothrombin 84
Validity of the modified stoke ankylosing spondylitis spine score (M-SASSS) and of the bath ankylosing spondylitis radiology index (BASRI) for the radiological assessment of axial involvement in psoriatic arthritis. multicentre validation study. Part one. 84
The performance of CASPAR criteria in early psoriatic arthritis - preliminary results from an Italian prospective multicentric study 83
Subcorneal pustular dermatosis (Sneddon-Wilkinson syndrome): another cutaneous manifestation of SAPHO syndrome? 83
Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis 83
Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate 83
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study 83
Etanercept in psoriatic arthritis 83
Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report 83
Supervised training and home-based rehabilitation in patients with stabilized ankylosing spondylitis on TNF inhibitor treatment: a controlled clinical trial with a 12-month follow-up 82
Unmet needs in outcome measures of Psoriatic Arthritis: focus on axial radiographic and nail involvement 82
Patient education in psoriatic arthritis: a cross sectional study on knowledge by a validated self-administered questionnaire 82
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study 82
Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients 82
Unmet Needs in Axial Spondyloarthritis 82
Treatment options: NSAIDs and DMARDs 81
Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: A cross-sectional analysis of a longitudinal cohort 81
The arthritis of ulcerative colitis: clinical and genetic aspects 80
Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: A systematic review. 80
Secukinumab for ankylosing spondylitis and psoriatic arthritis 80
Consensus on the management of patients with psoriatic arthritis in a dermatology setting 80
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis. 78
Defining low disease activity states in psoriatic arthritis using novel composite disease instruments 78
Assessment of subclinical atherosclerosis in ankylosing spondylitis: Correlations with disease activity indices 78
Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey. 77
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis 77
Updated guidelines for the management of axial disease in psoriatic arthritis 76
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 76
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications 76
Measuring psoriatic disease in clinical practice. An expert opinion position paper. 75
The role of IL-17 in the treatment of psoriatic arthritis 75
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings 75
An audit of anthropometric measurements by medical and physiotherapy staff in patients with ankylosing spondylitis 74
Predictors of loss of remission and disease flares in patients with axial spondyloarthritis receiving antitumor necrosis factor treatment: A retrospective study 74
The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept 74
Qualifying Unmet Needs and Improving Standards of Care in Psoriatic Arthritis. 73
Axonal degeneration in systemic sclerosis can be reverted by factors improving tissue oxygenation 73
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs 73
An overview of low disease activity and remission in psoriatic arthritis. 72
Beyond early diagnosis: occult psoriatic arthritis 72
Somatic perception in irritable bowel syndrome (IBS) patients with and without fibromyalgia (FMS). Does the severity of IBS influence the perception of somatic stimuli? 72
Psoriatic disease: Clinical staging 72
Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis 71
Aortic involvement in ankylosing spondylitis 71
ANTHROPOMETRIC MEASUREMENTS AND DISABILITY IN A OPEN FOLLOW UP STUDY ON ANKYLOSING SPONDYLITIS WITH COMBINED MEDICAL AND REHABILITATIVE TREATMENT 71
Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study. 71
The assessment of knowledge in ankylosing spondylitis patients by a self-administered questionnaire 71
L’educazione del paziente affetto da artrite reumatoide. 70
The effectiveness of rehabilitation in active ankylosing spondylitis assessed by the ASAS response criteria 70
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy 70
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection. 69
Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis 69
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 69
Subcutaneous anti-TNF alfa induced sustained minimal disease activity and remission in psoriatic arthritis patients: a retrospective study 69
Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists? 68
Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients. 67
Physical trauma triggers psoriasis in a patient with undifferentiated seronegative spondyloarthropathy 67
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review 66
Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis 66
Outcome measures in psoriatic arthritis 66
Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model 66
Multimorbidity and comorbidity in psoriatic arthritis–a perspective 66
Patient's global assessment as an outcome measure for psoriatic arthritis in clinical practice: A surrogate for measuring low disease activity? 66
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis. 65
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). 65
Reverse correlation between extent of colon involvement and number of affected joints in patients with ulcerative colitis and arthritis 65
Antiphospholipid syndrome, activated protein C resistance and mutation C -> T 677 in the MTHFR gene with juvenile pulmonary embolism. A case report 65
Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs 65
New insights in occult psoriatic arthritis 65
Juvenile rheumatoid arthritis, Crohn's disease and Turner's syndrome: a novel association 64
Pharmacoeconomic issues in psoriatic arthritis 64
Emerging drugs for psoriatic arthritis 64
Assessment of psoriatic nail disease activity by rheumatologists 64
Psoriatic Arthritis and Psoriasis Projects in Italy: A Report from the GRAPPA 2011 Meeting 64
The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods. 63
Psoriatic arthritis: imaging techniques 63
Fibromyalgia is strongly associated with the severity of inflammatory bowel syndrome. 63
New approaches in tumor necrosis factor antagonism for the treatment of psoriatic arthritis: Certolizumab pegol 63
The sex influence on response to tumor necrosis factor-α inhibitors and remission in axial spondyloarthritis 63
Role of comorbidities in spondyloarthritis including psoriatic arthritis 63
Pharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies 63
Interplay between environmental factors, articular involvement, and HLA-B27 in patients with psoriatic arthritis 63
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia 62
A novel biological target for the treatment of psoriatic arthritis. 62
Totale 7.580
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.528
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.437 21 23 183 69 171 54 280 94 215 91 54 182
2020/20211.591 27 178 9 243 273 102 199 20 206 17 266 51
2021/2022968 51 252 16 31 55 28 29 106 141 154 43 62
2022/20234.660 535 121 102 392 245 377 16 220 2.328 144 82 98
2023/2024850 237 132 54 20 30 72 18 47 19 46 84 91
2024/2025444 444 0 0 0 0 0 0 0 0 0 0 0
Totale 12.140